Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from PegBio Co., Ltd. Class H ( (HK:2565) ) is now available.
PegBio Co., Ltd. has announced amendments to its Articles of Association following the listing of its H shares on the main board of the Hong Kong Stock Exchange. These amendments were made to comply with regulatory requirements and reflect changes proposed by the relevant authority, which may impact the company’s operations and regulatory compliance.
More about PegBio Co., Ltd. Class H
PegBio Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the pharmaceutical industry. The company focuses on the production and wholesale of pharmaceuticals, research and development of biochemical technology, and sales of Class I medical devices.
Average Trading Volume: 1,216,492
See more data about 2565 stock on TipRanks’ Stock Analysis page.